What can we learn from kidney organoids?

Aude Dorison, Thomas A. Forbes, Melissa H. Little*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftReviewpeer review

18 Citationer (Scopus)

Abstract

The ability to generate 3-dimensional models of the developing human kidney via the directed differentiation of pluripotent stem cells—termed kidney organoids—has been hailed as a major advance in experimental nephrology. Although these provide an opportunity to interrogate human development, model-specific kidney diseases facilitate drug screening and even deliver bioengineered tissue; most of these prophetic end points remain to be realized. Indeed, at present we are still finding out what we can learn and what we cannot learn from this approach. In this review, we will summarize the approaches available to generate models of the human kidney from stem cells, the existing successful applications of kidney organoids, their limitations, and remaining challenges.

OriginalsprogEngelsk
TidsskriftKidney International
Vol/bind102
Udgave nummer5
Sider (fra-til)1013-1029
Antal sider17
ISSN0085-2538
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
This work was supported by the Medical Research Future Fund (2007286), the National Health and Medical Research Council (NHMRC) of Australia (GNT2011314), and the Novo Nordisk Foundation Center for Stem Cell Medicine (NNF21CC0073729). MHL holds an NHMRC Senior Principal Research Fellowship (GNT1136085). TAF is a clinician scientist fellow supported by the Royal Children's Hospital Foundation . The research conducted at the Murdoch Children’s Research Institute is supported by the Victorian Government’s Operational Infrastructure Support Program.

Publisher Copyright:
© 2022 International Society of Nephrology

Citationsformater